Q-omics provides the consensus-scored MTATP6P29 profile across patient tissues and cancer cell-line models. MTATP6P29 expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in PAAD. Additionally, MTATP6P29 RNA expression shows 3,796 significant protein co-abundance associations, with the highest sampling consensus in LUAD. Together, these results highlight PAAD, and LUAD as cancer lineages where MTATP6P29 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MTATP6P29 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MTATP6P29 survival associations across molecular data types. MTATP6P29 RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MTATP6P29 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	6	PAAD (99)	view →

This table ranks reproducible MTATP6P29 RNA expression–survival associations across cancer types. High MTATP6P29 expression shows unfavorable associations in PAAD, THYM, LUAD and HNSC, but favorable associations in OV and STAD. The PAAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify PAAD as the clearest survival context for MTATP6P29 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.160	0.619	<.001	99	view →
OV	DFS	Tertile	All	0.308	0.146	.005	48	view →
THYM	DFS	Tertile	All	0.050	0.885	<.001	36	view →
STAD	DFS	Tertile	III,IV	0.845	0.536	.016	21	view →
LUAD	DFS	Tertile	III,IV	0.206	0.670	.015	15	view →
HNSC	DFS	Tertile	IV	0.224	0.583	.021	9	view →

Pink = unfavorable, green = favorable. all 6 lineages →

MTATP6P29-PAAD (OS)

Kaplan–Meier survival curve for MTATP6P29 RNA expression in PAAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MTATP6P29 in patient tissues and cancer cell lines. In patient samples, MTATP6P29 shows the broadest associations at the RNA and protein expression levels, with LUAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	3,796	LUAD (1299)	view →
Function (RNA)	2,048	OV (728)	view →